Related Experiment Video
Updated: Jul 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin
Susan Boyle-Vavra1, Robert S Daum
1Department of Pediatrics, Section of Infectious Diseases, University of Chicago, Chicago, IL 60637, USA. sboyle@peds.bsd.uchicago.edu
Abstract:
Community-acquired (CA) methicillin-resistant Staphylococcus aureus (MRSA) infection among individuals without healthcare-associated (HA) risk factors was first recognized about a decade ago. It has now emerged as an epidemic that is responsible for rapidly progressive, fatal diseases including necrotizing pneumonia, severe sepsis and necrotizing fasciitis. Unlike HA-MRSA, CA-MRSA are usually pan-susceptible to non-beta-lactam antimicrobials. In addition to novel methicillin resistance genetic cassettes, many CA-MRSA harbor a phage harboring Panton-Valentine Leukocidin (PVL) genes and some data support the idea that PVL is responsible at least in part for the increased virulence of CA-MRSA. The tight association between the novel methicillin resistance cassettes and PVL phage cannot be explained, as they integrate into distinct sites on the S. aureus chromosome. This paper presents the evidence that CA-MRSA isolates are distinct strains emerging de novo from CA-methicillin susceptible isolates rather than from HA-MRSA isolates that have escaped from the hospital setting and that these novel CA-MRSA isolates may be more virulent than HA-MRSA. The second aim is to outline the progress in understanding the role of PVL in CA-MRSA pathogenesis.
Insights
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is an epidemic causing severe infections. These strains appear distinct from hospital-acquired MRSA and may be more virulent, partly due to Panton-Valentine Leukocidin (PVL).
Area of Science:
- Microbiology
- Infectious Diseases
- Epidemiology
Background:
- Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections have emerged as a significant epidemic.
- CA-MRSA causes severe, rapidly progressive diseases like necrotizing pneumonia, sepsis, and fasciitis, particularly in individuals without healthcare-associated risk factors.
- Unlike hospital-acquired MRSA (HA-MRSA), CA-MRSA strains are often susceptible to non-beta-lactam antibiotics.
Purpose of the Study:
- To present evidence suggesting CA-MRSA are distinct strains emerging independently from community-susceptible isolates.
- To explore the hypothesis that CA-MRSA may possess increased virulence compared to HA-MRSA.
- To outline advancements in understanding the role of Panton-Valentine Leukocidin (PVL) in CA-MRSA pathogenesis.
Main Methods:
- Comparative analysis of CA-MRSA and HA-MRSA isolates.
- Investigation of genetic elements, including novel methicillin resistance cassettes and PVL phage.
- Review of existing data on PVL's contribution to MRSA virulence.
Main Results:
- Evidence supports CA-MRSA as distinct strains originating de novo within the community.
- CA-MRSA isolates may exhibit greater virulence than HA-MRSA.
- Panton-Valentine Leukocidin (PVL) is frequently harbored by CA-MRSA and implicated in enhanced virulence.
Conclusions:
- CA-MRSA represents a unique and concerning public health threat.
- The distinct origin and potential for increased virulence of CA-MRSA warrant further investigation.
- Understanding the role of PVL is crucial for developing effective therapeutic and preventative strategies against CA-MRSA infections.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Atypical Pneumonia
Development of Antibiotic Resistance